AS
Alec Stranahan BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
4.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
50%
Neutral
35.7%
Negative
14.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Downgraded
| $7 |
13%
upside
| 2 | -25% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $12 |
8%
downside
| 1 | – |
–
| 3 Sep ‘25 1 month ago |
|
|
|
Underperform
Downgraded
| $1 |
59%
downside
| 2 | -45% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
|
Underperform
Downgraded
| $7 |
16%
downside
| 2 | +13% |
0
%
| 20 Aug ‘25 1 month ago |
|
|
|
Buy
Maintained
| $192 |
6%
upside
| 1 | +23% |
0
%
| 22 Jul ‘25 2 months ago |
|
|
|
Buy
Upgraded
| $42 |
60%
upside
| 1 | +19% |
0
%
| 28 Mar ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $12 | – | 1 | – |
–
| 5 Mar ‘25 7 months ago |
|
|
|
Buy
Maintained
| $25 |
245%
upside
| 1 | -41% |
0
%
| 7 Jan ‘25 9 months ago |
|
|
|
Buy
Maintained
| $11 |
342%
upside
| 1 | +32% |
0
%
| 7 Jan ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| $6 |
23%
upside
| 1 | – |
–
| 25 Nov ‘24 10 months ago |
|
|
|
Buy
Maintained
| $15 |
45%
upside
| 1 | +32% |
0
%
| 19 Nov ‘24 10 months ago |
|